361 related articles for article (PubMed ID: 21576512)
1. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.
McKinnell JA; Stollenwerk NS; Jung CW; Miller LG
Mayo Clin Proc; 2011 Jun; 86(6):480-8. PubMed ID: 21576512
[TBL] [Abstract][Full Text] [Related]
2. Cystitis treatment in women, circa 2011: new role for an old drug.
Schultz HJ; Edson RS
Mayo Clin Proc; 2011 Jun; 86(6):477-9. PubMed ID: 21628612
[No Abstract] [Full Text] [Related]
3. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
Le TP; Miller LG
Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
[TBL] [Abstract][Full Text] [Related]
4. Empiric treatment of uncomplicated UTI in women: wasting money when more is not better.
Kahan NR; Chinitz DP; Waitman DA; Kahan E
J Clin Pharm Ther; 2004 Oct; 29(5):437-41. PubMed ID: 15482387
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women.
Kahan NR; Kahan E; Waitman DA; Chinitz DP
Isr Med Assoc J; 2004 Oct; 6(10):588-91. PubMed ID: 15473583
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.
Hooton TM
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():65-72. PubMed ID: 14527774
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.
Garrison J; Hooton TM
Expert Opin Pharmacother; 2001 Aug; 2(8):1227-37. PubMed ID: 11584990
[TBL] [Abstract][Full Text] [Related]
8. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
Gupta K; Hooton TM; Stamm WE
Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
[TBL] [Abstract][Full Text] [Related]
9. Urinary tract infection: traditional pharmacologic therapies.
Nicolle LE
Am J Med; 2002 Jul; 113 Suppl 1A():35S-44S. PubMed ID: 12113870
[TBL] [Abstract][Full Text] [Related]
10. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections.
Cunha BA; Schoch PE; Hage JR
Mayo Clin Proc; 2011 Dec; 86(12):1243-4; author reply 1244. PubMed ID: 22134943
[No Abstract] [Full Text] [Related]
11. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
Langner JL; Chiang KF; Stafford RS
Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of uncomplicated urinary tract infections.
Guay DR
Drugs; 2008; 68(9):1169-205. PubMed ID: 18547131
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial agents for treating uncomplicated urinary tract infection in women.
Zalmanovici Trestioreanu A; Green H; Paul M; Yaphe J; Leibovici L
Cochrane Database Syst Rev; 2010 Oct; (10):CD007182. PubMed ID: 20927755
[TBL] [Abstract][Full Text] [Related]
14. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
Bradley MS; Beigi RH; Shepherd JP
Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance.
Miller LG; Tang AW
Mayo Clin Proc; 2004 Aug; 79(8):1048-53; quiz 1053-4. PubMed ID: 15301333
[TBL] [Abstract][Full Text] [Related]
16. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women.
Malik RD; Wu YR; Christie AL; Alhalabi F; Zimmern PE
Urology; 2018 Mar; 113():26-33. PubMed ID: 29196069
[TBL] [Abstract][Full Text] [Related]
17. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
19. Addressing antibiotic resistance.
Gupta K
Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
[TBL] [Abstract][Full Text] [Related]
20. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]